Advanced Search


Study ID Status Title Patient Level Data
113978 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine administered as a booster dose in 12-18 months old healthy children Study Listed on
113979 Completed Economic Analyses Alongside the REDUCE Clinical Trial
113984 Completed Dutasteride in Enlarged Prostate economic assessment: A retrospective database pooled analysis of early 5-alpha reductase inhibitor use
113985 Completed AVANDIA® (rosiglitazone maleate) 2009 Update to Integrated Cardiovascular (CV) Endpoint data from the Final Analyses for Studies BRL-049653/048 (ADOPT), AVD107642 (DREAM), and BRL-049653/231 (RECORD).
113989 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and FF Inhalation Powder in Japanese Subjects with asthma Study Listed on
113994 Completed Safety, reactogenicity & immunogenicity of GSK Biologicals’ pneumococcal vaccine 2189242A when co-administered with DTPa-HBV-IPV/Hib vaccine in healthy infants
114000 Completed A study to evaluate the safety and efficacy of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children aged 6 months to less than 10 years of age Study Listed on
114001 Completed Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
114002 Completed proportion of ocular symptoms in patients with allergic rhinitis in Korea
114005 Completed A Phase 1, Open Label, Single Sequence, Three Period Study to Evaluate the Single Dose Pharmacokinetics of GSK1349572 100mg versus 50mg and the Effect of Efavirenz 600mg Once Daily on the Pharmacokinetics, Safety and Tolerability of GSK1349572 50mg Once Daily in Healthy Adult Subjects (ING114005)
114009 Completed A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104 on the endotoxin induced inflammatory response in healthy male subjects Study Listed on
114010 Completed A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects with Type 2 Diabetes Mellitus Study Listed on
114011 Completed A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Study Listed on
114012 Relinquished A Study to Evaluate Efficacy and Safety of Pazopanib Monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, fallopian tube or primary peritoneal carcinoma – An extension study to VEG110655
114013 Completed Systematic review of the clinical and cost effectiveness of treatments for idiopathic (immune) thrombocytopenic purpura (ITP): direct meta analysis
114014 Completed Indirect Comparison of efficacy of treatments for idiopathic immune thrombocytopenic purpura - review of platelet responses and bleeding events
114015 Completed Meta-analysis of efficacy of Topotecan and other treatments for recurrent carcinoma of the cervix
114016 Completed Indirect Comparison of the efficacy between topotecan and other treatments for recurrent carcinoma of the cervix
114021 Completed A Study of Biomarker Profiles in Asia Pacific erbB2+/HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-erbB2/HER2 Therapy
114025 Completed A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group Study to Compare the Efficacy, Tolerability, and Safety of 3 Doses of Gabapentin Enacarbil (GSK1838262) With Placebo in the Treatment of Subjects With Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
114035 Completed Relative bioavailability study between the formulations: Paroxetine 25 mg tablets with controlled release manufactured by GSK Mississauga and Paroxetine 25 mg tablets with controlled release manufactured by SmithKline Beecham (Cidra), fed administration in healthy volunteers of both genders
114040 Completed Assessment of relative bioavailability of Avandamet 4 mg + 1000 mg (GSK) in the form of film coated tablets versus Avandamet 2 mg + 500 mg (GSK) in the form of film coated tablets, in healthy volunteers after feeding standardized, using Liquid Chromatography.
114041 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects Study Listed on
114043 Active, Not Recruiting Systematic Review and Meta-Analysis of the Impact of Alternative Treatments on Mortality Outcomes in Chronic Obstructive Pulmonary Disease (COPD)
114044 Completed A phase III, randomized, double blind, placebo-controlled clinical study to assess the efficacy and safety of GSK2402968 in subjects with Duchenne muscular dystrophy



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.